Dapeng Li

Dr. Dapeng Li

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 January 2025 in Theranostics
Verified
Journal Article
Open access
PDF file
XHXiukun Hou
Xiukun Hou
QDQiman Dong
Qiman Dong
JHJie Hao
Jie Hao
MLMin Liu
Min Liu
JNJunya Ning
Junya Ning
XZXiangqian Zheng
Xiangqian Zheng
Rationale: Anaplastic thyroid carcinoma (ATC) is an extraordinarily aggressive form of thyroid cancer, frequently presenting with locally advanced infiltration or distant metastases at the time of initial diagnosis, thus missing the optimal window for surgical intervention. Consequently, systemic chemotherapy and targeted therapies are vital for improving the prognosis of ATC. However, ATC exhibits significant resistance to conventional treatments, highlighting the need to elucidate the biological mechanisms underlying this drug resistance and identify novel therapeutic targets to overcome it.

1 December 2024 in Gland Surgery
Verified
Journal Article
Open access
PDF file
YGYing Gao
Ying Gao
MTMengran Tian
Mengran Tian
XHXiukun Hou
Xiukun Hou
WHWeijing Hao
Weijing Hao
YZYanhui Zhang
Yanhui Zhang
DLDapeng Li
Dapeng Li
Background: Multifocality is a distinctive feature of papillary thyroid carcinoma (PTC); however, the biological behavior of PTC and its optimal management strategy remain unclear. The aim of this study was to analyze the clinical features and prognostic differences of multifocal papillary carcinoma and to guide the precise treatment of multifocal papillary carcinoma. Methods: The medical records of 1,139 patients with PTC who had undergone total or hemi-thyroidectomy between April and October 2013 at the Tianjin Medical University Cancer Institute and Hospital were reviewed. The number of central compartment lymph node metastasis (LNM), as well as the size, number, and laterality of each tumor focus, along with other possible risk factors were recorded. Patients were followed up until May 2024. Results: According to univariate and multivariable analyses, PTC, multifocality, and male sex were risk factors for level VI LNM. Moreover, the central compartment LNM rate increased proportionally with the number of foci. The LNM rates for patients with unilateral papillary thyroid microcarcinoma (PTMC) having one, two, three, and four foci were 27.8% (146/525), 37.3% (55/142), 40% (14/35), and 57.1% (4/7), respectively; conversely, the LNM rates for patients with bilateral PTC having two, three, four, five, and six foci were 50% (15/30), 62.5% (15/24), 70% (7/10), 83.3% (5/6), and 100% (2/2), respectively. Notably, the LNM rates were comparable for multifocal PTMCs (largest tumor diameter: 6–10 mm) and unilateral unifocal PTCs [44.0% (55/125) vs. 60.8% (59/97); P=0.43 (0.42–0.93)]. Meanwhile, the survival rates and risk of recurrence were comparable for multifocal and unifocal PTCs. Conclusions: Multifocality is indicative of a heightened risk of LNM in PTC but does not increase the risk of recurrence or mortality. Multifocal PTMCs with a tumor diameter of 6–10 mm should undergo thorough preoperative evaluation of the regional lymph nodes as they have a higher risk of developing LNM.

30 June 2025 in Cancer Gene Therapy
Verified
Journal Article
Closed access
PDF file
XRXianhui Ruan
Xianhui Ruan
WZWei Zhang
Wei Zhang
XHXiukun Hou
Xiukun Hou
GFGuiming Fu
Guiming Fu
WMWeike Ma
Weike Ma
XZXiangqian Zheng
Xiangqian Zheng